Search clinical trials for: alteplase

Total 170 results

SOS Attaque Cérébrale

Terminated

Thrombectomy Under Reopro Versus Alteplase to Treat Stoke (TURANDOT)

Infarction, Middle Cerebral Artery

France
Genentech, Inc.

Completed

Cathflo Activase Pediatric Study

Dysfunctional Central Venous Access Devices (CVADS)
Boehringer Ingelheim

Completed

Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial Infarction

Myocardial Infarction

China, Korea, Republic of, Hong Kong
Ataturk University

Unknown

Comparison of Low-Molecular-Weight Heparin (LMWH) and Unfractionated Heparin (UFH) in Combination With Thrombolytic Treatment of Acute Massive Pulmonary Thromboembolism

This Study Will Provide Data Comparing Safety of LMWH Versus UFH in the Treatment of Acute PE Cases Who Require Thrombolytic Treatment.

Turkey
University of California, San Diego
National Institute of Neurological Disorders and Stroke (NINDS); Scripps Health

Withdrawn

Study for the Use of Alteplase in Patients Who Awaken With Stroke (AWOKE)

Ischemic Stroke

United States
ConvaTec Inc.

Completed

Compare Aquacel® Ag Versus Mepilex® Border Ag to Manage Bioburden in Leg Ulcers

Leg Ulcers

United Kingdom
Melbourne Health
Boehringer Ingelheim

Completed

Echoplanar Imaging Thrombolysis Evaluation Trial (EPITHET)

Stroke

Australia, New Zealand, Belgium, United Kingdom
National Institute of Neurological Disorders and...

Completed

Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST) (CATALIST)

Ischemic Stroke

United States
Midwest Pulmonary and Critical Care
Genentech, Inc.

Completed

Efficacy and Safety of Activase (Ateplase) vs Placebo in Complicated Pleural Effusions (CPE)/Empyemas (CPE)

Pleural Effusion Associated With Pulmonary Infection | Bacterial Pleural Effusion Other Than Tuberculosis

United States
Jacobs Neurological Institute
Genentech, Inc.; University at Buffalo Neurosurgery

Unknown

Wake up Symptomatic Stroke - Benefit of Intravenous Clot Busters or Endovascular Intervention (WASSABI)

Stroke

United States
Mitsubishi Tanabe Pharma Corporation
Kyowa Hakko Kogyo Co., Ltd.

Completed

Japan Alteplase Clinical Trial (J-ACT): Efficacy and Safety Study of Tissue Plasminogen Activator (Alteplase) for Ischemic Stroke

Brain Ischemia | Cerebral Infarction

Japan
University of Edinburgh
Umeå University; NHS Lothian

Completed

Diesel Exhaust Inhalation, Systemic Nitric Oxide Inhibition and Cardiac Output (DISCO)

Vascular Function in Healthy Volunteers

Sweden
University of North Carolina, Chapel Hill
Genentech, Inc.

Completed

IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion

Ischemic Stroke

United States
Hospital Universitari Vall d'Hebron Research Institute

Completed

Efficacy and Security of Intrapleurally Alteplase vs Urokinase for the Treatment of Complicated Parapneumonic Effusion and Empyema

Pleural Diseases | Pleural Effusion | Empyema, Pleural

Spain
Ever Neuro Pharma GmbH
JSW-Research Forschungslabor GmbH, Parkring 12, 8074 Grambach

Completed

Combined Treatment With Alteplase (Rt-PA) and Cerebrolysin® in Acute Ischemic Hemispheric Stroke (CERE-LYSE-1)

Stroke

Austria, Croatia, Czech Republic, Slovakia, Slovenia
University Hospital, Toulouse
Ministry of Health, France

Terminated

Microbubbles and Ultrasound in Stroke Trial: MUST Study

Acute Ischemic Stroke

France
AstraZeneca

Completed

DESOLO - SiT Peri-Launch: A Comparison of Symbicort Single Inhaler Therapy and Conventional Best Practice for the Treatment of Persistent Asthma in Adults

Asthma

Germany
University of Manitoba
Hoffmann-La Roche

Terminated

Alteplase for Blood Flow Restoration in Hemodialysis Catheters

Thrombosis

Canada
O'Brien, Jeana D., MD, FACP, FCCP
Genentech, Inc.; Texas A&M University; Scott and White Hospital & Clinic; Scott...

Unknown

Alteplase for Treatment of Empyema and Complicated Parapneumonic Effusion

Pleural Effusion | Empyema

United States
Astellas Pharma Inc
Astellas Pharma US, Inc.

Completed

A Study to Evaluate the Effects of YM872 on Brain Function and Disability When Administered in Combination With Alteplase (Tissue Plasminogen Activator)

Acute Ischemic Stroke

Canada, United States, Germany, Belgium, Austria

Search clinical trials for: alteplase

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in New Zealand

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations